NuCana PLC (NCNA)

NuCana PLC (NCNA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $4.1M; returns 1 day +2.6%, 1 week -0.5%, 1 year -76.5%.

NuCana plc is a clinical-stage biopharmaceutical company based in Edinburgh, United Kingdom, dedicated to developing novel treatments for cancer.

Groups NCNA belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Oncology
• United Kingdom Companies
• Healthcare
• Clinical Stage
• Cancer Therapeutics
• Life Sciences
• Pharmaceuticals
• R&D

NCNA financial model: income statement, cash flow and balance sheet